MARKET

CYBN

CYBN

Cybin Inc
AMEX
7.37
-0.15
-1.99%
After Hours: 7.37 0 0.00% 18:24 03/20 EDT
OPEN
7.49
PREV CLOSE
7.52
HIGH
7.60
LOW
7.28
VOLUME
97.38K
TURNOVER
--
52 WEEK HIGH
17.86
52 WEEK LOW
6.50
MARKET CAP
154.96M
P/E (TTM)
-1.8547
1D
5D
1M
3M
1Y
5Y
1D
Psychedelic: atai Life Sciences, NRx report quarterly results
TipRanks · 9h ago
Weekly Report: what happened at CYBN last week (0310-0314)?
Weekly Report · 3d ago
Cybin wins new Buy from Guggenheim: potential to challenge J&J’s Spravato cited
Seeking Alpha · 03/13 15:32
Guggenheim Initiates Coverage On Cybin with Buy Rating, Announces Price Target of $35
Benzinga · 03/13 15:23
'Nevada Senators Take Up Resolution Calling On Congress To Reschedule Psychedelics And Streamline Research' - Marijuana Moment
Benzinga · 03/12 15:45
Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress
TipRanks · 03/11 03:52
Weekly Report: what happened at CYBN last week (0303-0307)?
Weekly Report · 03/10 11:46
Psychedelic: MindMed reports Q4 earnings results
TipRanks · 03/06 16:31
More
About CYBN
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.

Webull offers Cybin Inc stock information, including AMEX: CYBN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYBN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CYBN stock methods without spending real money on the virtual paper trading platform.